Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Tofacitinib is an effective and safe treatment for alopecia areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

A 15-year-old boy was correctly diagnosed with a rare skin condition after initially being misdiagnosed.

Depression worsens eczema severity, increases inflammation, and lowers quality of life.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

Alopecia areata severity and child's age greatly affect the quality of life for children and their parents.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Disease-specific tools better assess quality of life in alopecia areata patients.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Activating autophagy in dogs with certain diseases improves their skin and hair.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

PRP treatment may help with alopecia areata, especially in newer cases.

Low vitamin D levels are common in people with Alopecia Areata.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.